HELYXON’s, A Health Tech Startup Can Help in Effective Monitoring of COVID 19 Patients & Better Manage the Pandemic
OXY 2, a real-time temperature, heart rate and oxygen saturation monitoring device can be used to monitor thousands of patients – at home or hospital – without the need for regular physical monitoring at one-tenth of the cost. AI-based biosensor device ’98.6 Fever Watch’ performs continuous temperature monitoring digitally and alerts doctors or attendants about any abnormal spike in temperature. The devices can be effectively used to remotely monitor COVID 19 patients, & are being actively sought by healthcare providers in North America, Middle East and Far East countries
With the COVID 19 outbreak overwhelming healthcare systems across the globe and creating an acute need for effective new age technologies for constant monitoring of patients, Indian IoT startup HELYXON’s AI-enabled devices are garnering attention as viable solutions for better management of the pandemic.
Constant and accurate monitoring of vital parameters of patients or suspects are critical components of managing coronavirus patients. Vital health parameters such as temperature, oxygen saturation as well as heart rate offer critical clues to the health condition of the patient and any aberration demands medical intervention. However, when the outbreak grows requiring remote monitoring of a huge number of suspected people, people at home or in isolation, monitoring and updating these parameters for all patients becomes a challenge. Here is where HELYXON’s digital solutions – ‘OXY-2’ and ‘98.6 Fever Watch’ offer an effective way to manage the outbreak.
HELYXON is a health tech startup that works in close collaboration with IITM’s Healthcare Technology Innovation Centre (HTIC) in IIT Madras Research Park, which works under the leadership of Prof. Mohanasankar Sivaprakasam. Oxy-2 and 98.6 FeverWatch are two deep tech innovations developed by HELYXON jointly with HTIC.
Helyxon is a pioneer in innovating such as devices and is best placed to provide this technology to India and the world ineffectively combating this health crisis. In fact, health authorities in North America, Middle East and Far East countries are actively seeking to deploy HELYXON’s technology in a major way in combating the COVID 19 pandemic.
“With the number of patients increasing exponentially and flooding hospitals, this is an overwhelming time for healthcare providers across the globe. What they need are appropriate technological interventions to help ease processes by automating as many mundane, critical and high-risk tasks, as possible. COVID 19 patients, particularly those deemed high risk, need continuous monitoring of temperature, heart rate as well as oxygen saturation as these parameters can oscillate suddenly and dangerously. Our AI-backed biosensor devices reliably captures trend of such parameters and alerts the remote medical staff or an attendant in case of any anomaly. This allows immediate intervention when needed; plus it also cuts down the work of regular manual monitoring which is in any case impossible for thousands of patients,” says Mr. Vijai Shankar Raja, Founder, HELYXON.
Headquartered in Chennai, HELYXON was founded by serial entrepreneur Vijai in 2014. HELYXON’s biosensor devices are designed in such a way that they enable the user to place them at the right places of the body and connect to a mobile device through Bluetooth. And the stream of data is further pushed to a cloud computer server through GSM or Wifi. The data from the server can be accessed by any authorized person especially the care providers across the globe easily using a mobile device or a Laptop. Similar path is used for the escalation of alerts raised out of breaches to reach the other end live.
The devices keep a track of the spikes and aberrations and whenever an anomaly is observed a system-generated call alert is made to the user while an automatic escalation to the local provider is done. The devices are equipped with Geo-fencing tracking alerts to keep a track of patients’ movements and ensure isolated patients do not violate the provisions of quarantine.
The 98.6 Fever Watch is particularly useful for unwell children in whom continuous monitoring of temperature is a vital parameter in disease management. The compact watch weighs 5 gm and is 1.5 inches in diameter. It connects to hospital systems or personal systems or devices and keeps transferring patient information to a central dashboard.
Globally, hospitals and healthcare providers are co-opting such technologies to improve healthcare efficiency in these testing times. To cite an instance, the Hong Kong Health Authority has recommended that all people who test positive, as well as those under quarantine, must wear a biosensor device that constantly measures oxygen levels, respiratory patterns, heart rate and temperature. Indian hospitals treating patients must also incorporate such technologies to boost their preparedness and efficiency.
